Integra LifeSciences Holdings Corporation

DB:IL3 Stock Report

Market Cap: €1.7b

Integra LifeSciences Holdings Future Growth

Future criteria checks 4/6

Integra LifeSciences Holdings is forecast to grow earnings and revenue by 113.7% and 5.8% per annum respectively. EPS is expected to grow by 110.5% per annum. Return on equity is forecast to be 17.2% in 3 years.

Key information

113.7%

Earnings growth rate

110.5%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate5.8%
Future return on equity17.2%
Analyst coverage

Good

Last updated13 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:IL3 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,7899918920510
12/31/20251,7117114517412
12/31/20241,6131388412
9/30/20241,565-738137N/A
6/30/20241,5672459142N/A
3/31/20241,5304061130N/A
12/31/20231,5426873140N/A
9/30/20231,543101110167N/A
6/30/20231,545131155208N/A
3/31/20231,562172200246N/A
12/31/20221,558181217264N/A
9/30/20221,565173188248N/A
6/30/20221,567166205263N/A
3/31/20221,559157232288N/A
12/31/20211,542169264312N/A
9/30/20211,526216274323N/A
6/30/20211,509206262310N/A
3/31/20211,378170203252N/A
12/31/20201,372134140204N/A
9/30/20201,37856155213N/A
6/30/20201,387-378207N/A
3/31/20201,5122783223N/A
12/31/20191,5185097231N/A
9/30/20191,5066047185N/A
6/30/20191,493101124200N/A
3/31/20191,47583109188N/A
12/31/20181,47261122200N/A
9/30/20181,45880103169N/A
6/30/20181,37170N/A135N/A
3/31/20181,28769N/A127N/A
12/31/20171,18865N/A115N/A
9/30/20171,07549N/A110N/A
6/30/20171,04766N/A111N/A
3/31/20171,01468N/A120N/A
12/31/201699275N/A116N/A
9/30/201698561N/A136N/A
6/30/20169589N/A108N/A
3/31/20169199N/A98N/A
12/31/20158837N/A105N/A
9/30/201585412N/A100N/A
6/30/201582753N/A111N/A
3/31/201578246N/A100N/A
12/31/201479736N/A84N/A
9/30/201479830N/A70N/A
6/30/2014814-10N/A70N/A
3/31/2014855-13N/A57N/A
12/31/201369722N/A53N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IL3 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: IL3 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: IL3 is expected to become profitable in the next 3 years.

Revenue vs Market: IL3's revenue (5.8% per year) is forecast to grow faster than the German market (5.7% per year).

High Growth Revenue: IL3's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: IL3's Return on Equity is forecast to be low in 3 years time (17.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y